CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM – 2018 EXECUTIVE SUMMARY
This document represents the official position of the American Association of Clinical Endocrinologists and American
College of Endocrinology. Where there were no randomized controlled trials or specific U.S. FDA labeling for issues
in clinical practice, the participating clinical experts utilized their judgment and experience. Every effort was made to
achieve consensus among the committee members. Position statements are meant to provide guidance, but they are not to
be considered prescriptive for any individual patient and cannot replace the judgment of a clinician.